Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
|Articles|August 17, 2021
Pharmacy Clinical Pearl of the Day: Comprehensive Metabolic Panel vs Complete Blood Count Labs
Author(s)Saro Arakelians, PharmD
Physicians may ask for either or both of comprehensive metabolic panel or complete blood count tests every 3 to 6 months, based on the conditions patients have.
Advertisement
Clinical Pearl of the Day: Comprehensive Metabolic Panel vs Complete Blood Count Labs
- Complete Blood Count (CBC): A CBC lab helps your health professional diagnose conditions such as infection, anemia, and several other disorders.
- Comprehensive Metabolic Panel (CMP-14): With eGFR is a group of 14 laboratory tests ordered to give information about the status of the liver, kidneys, and electrolyte and acid/base balance.
Explanation:
- CBC gives important information about the numbers and kinds of cells in the blood, especially red blood cells, white blood cells, and platelets.
CMP-14 tests give the status of blood sugar and blood proteins. Physicians may ask for one or both of these tests every 3 to 6 months, based on the disease conditions the patient may have.
Reference
Advertisement
Related to this article
An MRD-guided strategy incorporating teclistamab-daratumumab intensification produced deep responses in newly diagnosed high-risk multiple myeloma, although infections affected more than three-fourths of treated patients.
Phase 2 MILESTONE results suggest that postinduction minimal residual disease (MRD) negativity can identify a small subset of transplant-eligible patients with newly diagnosed multiple myeloma who may defer autologous stem cell transplantation.
Fixed-duration KRd slowed progression in high-risk smoldering myeloma, but high rates of severe toxicity temper enthusiasm.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What the 2025-2030 Dietary Guidelines Mean for Heart Health
2
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
3
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
4
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
5